Follow the 얼라인드 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 얼라인드 has logged 11 reports. The latest transaction was filed on 26 June 2026 (Purchase). Among the most active insiders: 정연철. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Aligné is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.